These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia. Litzow MR Curr Opin Hematol; 2007 Mar; 14(2):130-7. PubMed ID: 17255790 [TBL] [Abstract][Full Text] [Related]
85. Early splenectomy and polychemotherapy versus polychemotherapy alone in chronic myeloid leukemia. Baccarani M; Corbelli G; Tura S Leuk Res; 1981; 5(2):149-57. PubMed ID: 6941053 [No Abstract] [Full Text] [Related]
86. [Considerations on a case of acute myeloid leukemia treated with cortisone]. LISBOA AM Rev Med Aeron; 1952 Dec; 4(4):23-36. PubMed ID: 13047934 [No Abstract] [Full Text] [Related]
87. Bacteria on a peripheral blood smear as presenting sign of overwhelming post-splenectomy infection in a patient with secondary acute myeloid leukemia. Robier C; Schoberl M; Reiher H; Neubauer M Clin Chem Lab Med; 2015 Jul; 53(8):e203-5. PubMed ID: 25816311 [No Abstract] [Full Text] [Related]
88. [Effect of exchange blood transfusion on clinical and hematological picture of acute myeloid leukemia; review of literature and report of two cases]. SZERESZEWSKA H; SZEWCZYKOWSKI W Pol Tyg Lek (Wars); 1953 Jun; 8(23):809-14; contd. PubMed ID: 13088451 [No Abstract] [Full Text] [Related]
89. [Splenectomy in chronic granulocytic leukemia]. Ponce de León S Gac Med Mex; 1983 Oct; 119(10):423-6. PubMed ID: 6581109 [No Abstract] [Full Text] [Related]
90. Splenectomy in chronic myelocytic leukaemia. Berlin R Acta Med Scand; 1975 Mar; 197(3):145-6. PubMed ID: 1054904 [No Abstract] [Full Text] [Related]
91. Effects of N-methylacetamide and splenectomy on RF murine myeloid leukemia. Preisler H; Bjornsson S; Pavelic Z Leuk Res; 1979; 3(4):249-51. PubMed ID: 293455 [No Abstract] [Full Text] [Related]
92. Improving outcomes in myeloid leukemia patients: does a new DNA vaccine hold the answer? Rezvani K; de Lavallade H Expert Rev Vaccines; 2011 Jul; 10(7):933-5. PubMed ID: 21806391 [No Abstract] [Full Text] [Related]
93. The treatment of acute myelocytic leukemia. Ablin AR Calif Med; 1972 Dec; 117(6):62-3. PubMed ID: 4508368 [No Abstract] [Full Text] [Related]
94. [ACUTE PARAMYELOBLASTIC LEUKOSIS WITH EXCLUSIVE MENINGEAL RELAPSE]. OLMER J; MONGIN M; GABRIEL B Mars Med; 1964; 101():945-6. PubMed ID: 14247914 [No Abstract] [Full Text] [Related]
95. [Therapy of chronic myeloic leukemia]. Hunstein W Verh Dtsch Ges Inn Med; 1973; 79():334-9. PubMed ID: 4524454 [No Abstract] [Full Text] [Related]
96. [About the influence of splenectomy on the course of myeloid leukemia]. PUORGER G; AYMON G Schweiz Med Wochenschr; 1948 Aug; 78(31):762-5. PubMed ID: 18876229 [No Abstract] [Full Text] [Related]
97. [Contribution to the knowledge of bleeding manifestations in leukemics; haemartri during chronic myeloid leukemia]. MAURI C; REGGIANI G G Clin Med; 1947 Nov; 28(11):649-62. PubMed ID: 18898119 [No Abstract] [Full Text] [Related]
98. Guest editorial: introducing progress in hematology in this issue. Naoe T Int J Hematol; 2012 Aug; 96(2):151-2. PubMed ID: 22907733 [No Abstract] [Full Text] [Related]
99. Biologic agents for the management of hematological disorders: chronic myeloid leukemia. McCredie KB; Talpaz M; Kantarjian H; Rosenblum M; Keating M; Gutterman J Haematol Blood Transfus; 1987; 31():120-2. PubMed ID: 2450815 [No Abstract] [Full Text] [Related]